全文获取类型
收费全文 | 7414篇 |
免费 | 457篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 377篇 |
妇产科学 | 107篇 |
基础医学 | 715篇 |
口腔科学 | 118篇 |
临床医学 | 507篇 |
内科学 | 1826篇 |
皮肤病学 | 163篇 |
神经病学 | 512篇 |
特种医学 | 208篇 |
外科学 | 1337篇 |
综合类 | 157篇 |
一般理论 | 2篇 |
预防医学 | 377篇 |
眼科学 | 176篇 |
药学 | 597篇 |
中国医学 | 31篇 |
肿瘤学 | 602篇 |
出版年
2023年 | 71篇 |
2022年 | 157篇 |
2021年 | 250篇 |
2020年 | 146篇 |
2019年 | 233篇 |
2018年 | 251篇 |
2017年 | 166篇 |
2016年 | 225篇 |
2015年 | 194篇 |
2014年 | 295篇 |
2013年 | 387篇 |
2012年 | 544篇 |
2011年 | 542篇 |
2010年 | 346篇 |
2009年 | 270篇 |
2008年 | 430篇 |
2007年 | 483篇 |
2006年 | 365篇 |
2005年 | 360篇 |
2004年 | 286篇 |
2003年 | 257篇 |
2002年 | 229篇 |
2001年 | 86篇 |
2000年 | 99篇 |
1999年 | 100篇 |
1998年 | 51篇 |
1997年 | 31篇 |
1996年 | 48篇 |
1995年 | 34篇 |
1994年 | 27篇 |
1993年 | 31篇 |
1992年 | 65篇 |
1991年 | 58篇 |
1990年 | 32篇 |
1989年 | 46篇 |
1988年 | 45篇 |
1987年 | 42篇 |
1986年 | 36篇 |
1985年 | 33篇 |
1984年 | 24篇 |
1983年 | 33篇 |
1982年 | 29篇 |
1979年 | 20篇 |
1976年 | 25篇 |
1975年 | 28篇 |
1974年 | 27篇 |
1973年 | 23篇 |
1971年 | 27篇 |
1970年 | 30篇 |
1969年 | 26篇 |
排序方式: 共有7901条查询结果,搜索用时 15 毫秒
1.
2.
3.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献4.
5.
6.
Ajay Punpale C S Pramesh Nirmala Jambhekar Rajesh C Mistry 《Annals of thoracic and cardiovascular surgery》2006,12(6):425-427
Liposarcomas are extremely rare in the mediastinum. They may achieve considerable size before causing any symptoms. Mediastinal liposarcomas may invade surrounding structures like the pericardium or the superior vena cava. Complete surgical excision is the optimal treatment in resectable cases. Excision of adjacent structures like the pericardium may be needed if the tumor infiltrates them. We report on a case of a giant liposarcoma of the mediastinum involving both hemithoraces and extending into the neck, which was successfully managed by complete surgical excision. 相似文献
7.
YS Nagar S Singh V Sawlani L Pal K Dimri P Lal 《Journal of Medical Imaging and Radiation Oncology》2005,49(2):160-162
A rare case of an advanced primary broad ligament carcinoma is discussed, with a review of the literature regarding its incidence, presentation and management. This patient showed a complete response to adjuvant cisplatin-based chemotherapy following panhysterectomy and is presently without any evidence of disease, 15 months after completion of her treatment. 相似文献
8.
Since the first transurethral resection of the prostate (TURP) was performed by Guyon at the Necker Hospital in Paris in 1901,
this treatment modality has replaced open prostatectomy as the procedure of choice for more than 95% of patients. TURP has
been used in surgical treatment of benign prostatic hyperplasia (BPH) and remains the gold standard treatment. Transurethral
vapor resection of the prostate (TUVRP) and holmium laser enucleation of the prostate (HoLEP) are new treatment modalities
for the treatment of BPH. Each procedure has its own advantages and disadvantages. Availability of instruments, surgical expertise,
and specific indications for a particular procedure are of utmost importance for successful outcome, with minimal morbidity.
TURP can be either monopolar or bipolar, using thin or thick loop. Bipolar TURP is associated with less bleeding and less
chances of dilutional hyponatremia. TUVRP, using a thick wedge loop, causes vaporization and resection of the prostate, and
is associated with less bleeding and short operative time. HoLEP is another effective alternative for the surgical treatment
of BPH. The holmium laser possesses the ideal combination of cutting and coagulation; however, it has a learning curve. 相似文献
10.
A 50 year old man with a two month history of upper abdominal pain and a one month history of anorexia and weight loss, presented
with icterus and evidence of peritonitis. Laparotomy revealed biliary peritonitis which had been caused by a rupture of the
fundus of the gallbladder. The common bile duct was dilated and there was a large growth in the head of the pancreas with
multiple hepatic metastases. A cholecysto-jejunostomy and gastrojejunostomy were done and the patient had an uneventful recovery. 相似文献